Verition Fund Management’s Teladoc Health TDOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-17,500
Closed -$161K 3521
2024
Q3
$161K Hold
17,500
﹤0.01% 2932
2024
Q2
$171K Buy
+17,500
New +$213K ﹤0.01% 2642
2021
Q3
Sell
-185,000
Closed -$30.8M 2297
2021
Q2
$30.8M Sell
185,000
-15,000
-8% -$2.43M 0.28% 55
2021
Q1
$36.4M Buy
+200,000
New +$46.4M 0.41% 30

Other funds holding TDOC

Verition Fund Management's TDOC Position: Q1 2026 in Review

Verition Fund Management reduced its Teladoc Health (TDOC) stake by 90% in Q1 2026, selling an estimated $1.73M and leaving 35,379 shares worth $193K. The position accounts for ﹤0.01% of the portfolio, ranked #1956.

Verition Fund Management first reported a position in TDOC in Q2 2019 and has held it in 19 quarters since. The position peaked at $2.53M in Q3 2019. 322 funds tracked by Wall St. Rank hold TDOC as of Q1 2026.

  • Verition Fund Management held 35,379 shares of Teladoc Health worth $193K as of Q1 2026.
  • Verition Fund Management sold 308,537 Teladoc Health shares in Q1 2026, an estimated $1.73M.
  • Teladoc Health made up ﹤0.01% of Verition Fund Management's portfolio in Q1 2026, its #1956 holding.
  • Verition Fund Management first reported a position in Teladoc Health in Q2 2019 and has held it in 19 quarters since.
  • Verition Fund Management's Teladoc Health position peaked at $2.53M in Q3 2019.
  • 322 funds tracked by Wall St. Rank held Teladoc Health as of Q1 2026.

Based on Verition Fund Management's 13F filing for Q1 2026, filed 15 May 2026.